Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Biogen Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Biogen Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 76,032 shares of BIIB stock, worth $11.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

76,032

Previous 22,471 238.36%

Holding current value

$11.1 Million

Previous $5.21 Million 182.93%

% of portfolio

0.02%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $10.1 Million - $12.7 Million	53,561 Added 238.36%	76,032 $14.7 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $712,544 - $885,332	-3,740 Reduced 14.27%	22,471 $5.21 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $2.13 Million - $2.69 Million	-10,054 Reduced 27.72%	26,211 $5.65 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $365,937 - $440,493	1,644 Added 4.75%	36,265 $9.38 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $358,419 - $404,534	1,415 Added 4.26%	34,621 $8.9 Million
Q2 2023 May 17, 2024	BUY	$275.25 - $318.06 $1.93 Million - $2.22 Million	6,995 Added 26.69%	33,206 $9.46 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $2.5 Million - $2.89 Million	9,080 Added 37.64%	33,206 $9.46 Million
Q1 2023 May 17, 2024	SELL	$256.56 - $292.34 $9.25 Million - $10.5 Million	-36,045 Reduced 59.9%	24,126 $6.71 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $9.25 Million - $10.5 Million	-36,045 Reduced 59.9%	24,126 $6.71 Million
Q4 2022 May 17, 2024	BUY	$252.44 - $306.72 $8.57 Million - $10.4 Million	33,960 Added 129.56%	60,171 $16.7 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $1.55 Million - $1.88 Million	6,129 Added 11.34%	60,171 $16.7 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $4.99 Million - $6.88 Million	25,641 Added 90.28%	54,042 $14.4 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $2.14 Million - $2.54 Million	11,400 Added 67.05%	28,401 $5.79 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $3.01 Million - $3.87 Million	-13,445 Reduced 44.16%	17,001 $4.08 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $2.06 Million - $2.69 Million	-7,288 Reduced 19.31%	30,446 $8.62 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $2.35 Million - $3.76 Million	9,065 Added 31.62%	37,734 $13.1 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $4 Million - $4.68 Million	-16,457 Reduced 36.47%	28,669 $8.02 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $13.9 Million - $21 Million	-58,976 Reduced 56.65%	45,126 $11 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $10.4 Million - $12.1 Million	-39,425 Reduced 27.47%	104,102 $29.5 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $17 Million - $22.5 Million	65,594 Added 84.17%	143,527 $38.4 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $18.7 Million - $23.7 Million	-69,522 Reduced 47.15%	77,933 $24.7 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $7.47 Million - $10.3 Million	-33,934 Reduced 18.71%	147,455 $43.7 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $3.51 Million - $3.94 Million	-16,157 Reduced 8.18%	181,389 $42.2 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $7.81 Million - $8.61 Million	-35,636 Reduced 15.28%	197,546 $46.2 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $110 Million - $173 Million	-509,117 Reduced 68.59%	233,182 $55.1 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $41.2 Million - $52.1 Million	-147,775 Reduced 16.6%	742,299 $218 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $17.6 Million - $23 Million	59,889 Added 7.21%	890,074 $0
Q2 2018 Apr 15, 2019	BUY	$257.52 - $306.91 $331,428 - $394,993	1,287 Added 0.16%	830,185 $241 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $24.3 Million - $28.9 Million	94,239 Added 12.83%	828,898 $241 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $205,242 - $290,280	-789 Reduced 0.11%	734,659 $201 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $90.1 Million - $101 Million	-292,979 Reduced 28.49%	735,448 $234 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $289 Million - $339 Million	1,028,427	1,028,427 $322 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Biogen Inc. Transaction History